213 related articles for article (PubMed ID: 36340999)
1. Cancer Cure and Consequences on Survivorship Care: Position Paper from the Italian Alliance Against Cancer (ACC) Survivorship Care Working Group.
Dal Maso L; Santoro A; Iannelli E; De Paoli P; Minoia C; Pinto M; Bertuzzi AF; Serraino D; De Angelis R; Trama A; Haupt R; Pravettoni G; Perrone M; De Lorenzo F; Tralongo P;
Cancer Manag Res; 2022; 14():3105-3118. PubMed ID: 36340999
[TBL] [Abstract][Full Text] [Related]
2. Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy.
AIRTUM Working Group
Epidemiol Prev; 2014; 38(6 Suppl 1):1-122. PubMed ID: 25759295
[TBL] [Abstract][Full Text] [Related]
3. Cancer cure for 32 cancer types: results from the EUROCARE-5 study.
Dal Maso L; Panato C; Tavilla A; Guzzinati S; Serraino D; Mallone S; Botta L; Boussari O; Capocaccia R; Colonna M; Crocetti E; Dumas A; Dyba T; Franceschi S; Gatta G; Gigli A; Giusti F; Jooste V; Minicozzi P; Neamtiu L; Romain G; Zorzi M; De Angelis R; Francisci S;
Int J Epidemiol; 2020 Oct; 49(5):1517-1525. PubMed ID: 32984907
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival, prevalence, and cure of cancer: a population-based estimation for 818 902 Italian patients and 26 cancer types.
Dal Maso L; Guzzinati S; Buzzoni C; Capocaccia R; Serraino D; Caldarella A; Dei Tos AP; Falcini F; Autelitano M; Masanotti G; Ferretti S; Tisano F; Tirelli U; Crocetti E; De Angelis R; ; Virdone S; Zucchetto A; Gigli A; Francisci S; Baili P; Gatta G; Castaing M; Zanetti R; Contiero P; Bidoli E; Vercelli M; Michiara M; Federico M; Senatore G; Pannozzo F; Vicentini M; Bulatko A; Pirino DR; Gentilini M; Fusco M; Giacomin A; Fanetti AC; Cusimano R
Ann Oncol; 2014 Nov; 25(11):2251-2260. PubMed ID: 25149707
[TBL] [Abstract][Full Text] [Related]
5. Indicators of cure for women living after uterine and ovarian cancers: a population-based study.
Giudici F; De Paoli A; Toffolutti F; Guzzinati S; Francisci S; Bucchi L; Gatta G; Demuru E; Mallone S; Cin AD; Caldarella A; Cuccaro F; Migliore E; Gambino ML; Ravaioli A; Puppo A; Ferrante M; Carrozzi G; Stracci F; Musolino A; Gasparotti C; Cavallo R; Mazzucco W; Vitale MF; Cascone G; Ballotari P; Ferretti S; Mangone L; Rizzello RV; Sampietro G; Mian M; Boschetti L; Galasso R; Bella F; Piras D; Sessa A; Seghini P; Fanetti AC; Pinna P; De Angelis R; Serraino D; Maso LD; Working Group A
Am J Epidemiol; 2024 Apr; ():. PubMed ID: 38629583
[TBL] [Abstract][Full Text] [Related]
6. Prognosis and cure of long-term cancer survivors: A population-based estimation.
Dal Maso L; Panato C; Guzzinati S; Serraino D; Francisci S; Botta L; Capocaccia R; Tavilla A; Gigli A; Crocetti E; Rugge M; Tagliabue G; Filiberti RA; Carrozzi G; Michiara M; Ferretti S; Cesaraccio R; Tumino R; Falcini F; Stracci F; Torrisi A; Mazzoleni G; Fusco M; Rosso S; Tisano F; Fanetti AC; Sini GM; Buzzoni C; De Angelis R;
Cancer Med; 2019 Aug; 8(9):4497-4507. PubMed ID: 31207165
[TBL] [Abstract][Full Text] [Related]
7. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
8. Complete prevalence and indicators of cancer cure: enhanced methods and validation in Italian population-based cancer registries.
Toffolutti F; Guzzinati S; De Paoli A; Francisci S; De Angelis R; Crocetti E; Botta L; Rossi S; Mallone S; Zorzi M; Manneschi G; Bidoli E; Ravaioli A; Cuccaro F; Migliore E; Puppo A; Ferrante M; Gasparotti C; Gambino M; Carrozzi G; Stracci F; Michiara M; Cavallo R; Mazzucco W; Fusco M; Ballotari P; Sampietro G; Ferretti S; Mangone L; Rizzello RV; Mian M; Cascone G; Boschetti L; Galasso R; Piras D; Pesce MT; Bella F; Seghini P; Fanetti AC; Pinna P; Serraino D; Dal Maso L;
Front Oncol; 2023; 13():1168325. PubMed ID: 37346072
[TBL] [Abstract][Full Text] [Related]
9. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
10. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
11. Major patterns of cancer cure: Clinical implications.
Tralongo P; Surbone A; Serraino D; Dal Maso L
Eur J Cancer Care (Engl); 2019 Nov; 28(6):e13139. PubMed ID: 31436897
[TBL] [Abstract][Full Text] [Related]
12. Toward the development of a vibrant, super-aged society: The future of medicine and society in Japan.
Iijima K; Arai H; Akishita M; Endo T; Ogasawara K; Kashihara N; Hayashi YK; Yumura W; Yokode M; Ouchi Y
Geriatr Gerontol Int; 2021 Aug; 21(8):601-613. PubMed ID: 34212470
[TBL] [Abstract][Full Text] [Related]
13. Italian cancer figures, report 2010: Cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients.
AIRTUM Working Group
Epidemiol Prev; 2010; 34(5-6 Suppl 2):1-188. PubMed ID: 21220827
[TBL] [Abstract][Full Text] [Related]
14. Responding to the challenges of breast cancer in egypt and other arab countries.
El Saghir NS
J Egypt Natl Canc Inst; 2008 Dec; 20(4):309-12. PubMed ID: 20571588
[TBL] [Abstract][Full Text] [Related]
15. Patient-Reported Survivorship Care Practices and Late Effects After Treatment of Hodgkin and Non-Hodgkin Lymphoma.
Frick MA; Vachani CC; Hampshire MK; Bach C; Arnold-Korzeniowski K; Metz JM; Hill-Kayser CE
JCO Clin Cancer Inform; 2018 Dec; 2():1-10. PubMed ID: 30652594
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the status of a National Action Plan for Cancer Survivorship in the USA.
Smith JL; Pollack LA; Rodriguez JL; Hawkins NA; Smith T; Rechis R; Miller A; Willis A; Miller H; Hall IJ; Fairley TL; Stone-Wiggins B
J Cancer Surviv; 2013 Sep; 7(3):425-38. PubMed ID: 23609522
[TBL] [Abstract][Full Text] [Related]
17. Experiences of resuming life after immunotherapy and associated survivorship care needs: a qualitative study among patients with metastatic melanoma.
Kamminga NCW; van der Veldt AAM; Joosen MCW; de Joode K; Joosse A; Grünhagen DJ; Nijsten TEC; Wakkee M; Lugtenberg M
Br J Dermatol; 2022 Sep; 187(3):381-391. PubMed ID: 35596713
[TBL] [Abstract][Full Text] [Related]
18. Time-to-cure and cure proportion in solid cancers in France. A population based study.
Romain G; Boussari O; Bossard N; Remontet L; Bouvier AM; Mounier M; Iwaz J; Colonna M; Jooste V;
Cancer Epidemiol; 2019 Jun; 60():93-101. PubMed ID: 30933890
[TBL] [Abstract][Full Text] [Related]
19. Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (Teenage and Young Adult Cancer Survivor Study): a population-based, cohort study.
Bright CJ; Reulen RC; Winter DL; Stark DP; McCabe MG; Edgar AB; Frobisher C; Hawkins MM
Lancet Oncol; 2019 Apr; 20(4):531-545. PubMed ID: 30797674
[TBL] [Abstract][Full Text] [Related]
20. Integrated, cross-sectoral psycho-oncology (isPO): a new form of care for newly diagnosed cancer patients in Germany.
Kusch M; Labouvie H; Schiewer V; Talalaev N; Cwik JC; Bussmann S; Vaganian L; Gerlach AL; Dresen A; Cecon N; Salm S; Krieger T; Pfaff H; Lemmen C; Derendorf L; Stock S; Samel C; Hagemeier A; Hellmich M; Leicher B; Hültenschmidt G; Swoboda J; Haas P; Arning A; Göttel A; Schwickerath K; Graeven U; Houwaart S; Kerek-Bodden H; Krebs S; Muth C; Hecker C; Reiser M; Mauch C; Benner J; Schmidt G; Karlowsky C; Vimalanandan G; Matyschik L; Galonska L; Francke A; Osborne K; Nestle U; Bäumer M; Schmitz K; Wolf J; Hallek M
BMC Health Serv Res; 2022 Apr; 22(1):543. PubMed ID: 35459202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
